Ipamorelin and CJC-1295: what stacked GH-axis research actually measures
The synergy claim has real pharmacology behind it — and important measurement caveats.
ScienceAlso known as: NNC 26-0161
Ipamorelin is a pentapeptide ghrelin-receptor agonist noted in early studies for selective GH release without significant cortisol or prolactin elevation. Clinical development (originally for post-operative ileus) was discontinued, leaving it in research-chemical circulation.
Ipamorelin, the first selective growth hormone secretagogue
Characterized selective GH release without significant cortisol/prolactin elevation.
Laboratory verification of Ipamorelin products across the companies we index.
The synergy claim has real pharmacology behind it — and important measurement caveats.
ScienceThe Peptide Institute Weekly
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.